SHERIDAN, Wyo., Sept. 22, 2026 /PRNewswire/ -- The global lateral flow assay market is projected to grow from USD 11.04 billion in 2026 to USD 16.37 billion by 2031, registering a CAGR of 8.2% during ...
A recent study published on the medRxiv* preprint server discusses the role of lateral flow device (LFD) testing in potentially improving coronavirus disease 2019 (COVID-19) isolation policies. Study: ...
In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences Company) about the possibilities lateral flow assays offer in both the present and potential ...
Lateral flow immunoassay tests (or LFTs, for short) have been in use for decades, becoming an indispensable tool within diagnostics’ (Dx) practice, as well as a growing range of applications outside ...